Cuilan Li/LinkedIn
Nov 19, 2025, 15:56
Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
Cuilan Li, Founder and CEO at You First Consulting, shared on LinkedIn:
”Today I had the chance to contribute my expertise in hematology and oncology to a cutting-edge project in Polycythemia Vera (PV).
It was insightful, forward-thinking, and a powerful reminder of how real-world clinical insights empower the next wave of pharmaceutical and technology-driven innovation.
Proud to support projects that move science forward and strengthen clinical excellence.”
Stay updated with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:43Mohannad G Abdelgader: Understanding Thrombosis – Silent But Serious